Ribal Merhi
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Topical imiquimod in the management of botulinum toxin-induced upper eyelid ptosis: A case series.
Journal: JAAD case reports
Published: March 20, 2026
Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin.
Journal: Science advances
Published: December 10, 2025
Evaluation of the repigmentation of facial vitiligo using an AI algorithm in a phase 2 study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 10, 2025
Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo: A Randomized Clinical Trial.
Journal: JAMA dermatology
Published: January 22, 2025
Clinical heterogeneity in vitiligo: Identification of clinical markers based patient clusters.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 12, 2024
Unveiling the Unseen: Exploring Cellular Dynamics in Nonlesional Vitiligo Skin.
Journal: The Journal of investigative dermatology
Published: June 27, 2024
Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: Appearances can be deceptive.
Journal: The Journal of allergy and clinical immunology
Published: September 12, 2023
Efficacy and safety of the combination of steroid pulse therapy with methotrexate for vitiligo: A pilot retrospective case series.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 25, 2023
Evaluation of Facial Vitiligo Severity with a Mixed Clinical and Artificial Intelligence Approach.
Journal: The Journal of investigative dermatology
Published: February 17, 2023
Assessment of Vitiligo Area Scoring Index (VASI), Facial-VASI and Vitiligo Extent Score using standardized photography of patients with vitiligo.
Journal: The British journal of dermatology
Published: August 30, 2021
Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling.
Journal: The Journal of investigative dermatology
Published: April 05, 2021
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 09, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026